What is the classification and treatment of incydentaloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification and Management of Incidentalomas

Incidentalomas should be classified based on anatomical location, histological features, and risk stratification to guide appropriate management decisions.

Definition and General Approach

An incidentaloma is an asymptomatic mass or lesion discovered incidentally during imaging studies or procedures performed for unrelated reasons. The classification and management approach varies significantly based on the anatomical location and histological characteristics.

Classification Systems by Anatomical Location

1. Breast Incidentalomas

  • Fat Necrosis: Once histologically confirmed, clinical observation is appropriate with most cases resolving within 2-3 years 1
    • Regular follow-up: Every 3-4 months during first 2 years, every 6 months from years 3-5, annually thereafter
    • Imaging: Mammography every 1-2 years, with consideration of MRI in young patients with dense breast tissue

2. Ductal Carcinoma In Situ (DCIS)

  • Traditional Classification: Comedo, cribriform, micropapillary, papillary, and solid subtypes 2
  • Modern Classification: Based primarily on nuclear grade and/or necrosis rather than architectural pattern 2
    • Nuclear grade (low, intermediate, high)
    • Presence/absence of necrosis
    • Cell polarization

3. Oral Cavity and Oropharyngeal Incidentalomas

  • TNM Classification: Should be applied with lower (less advanced) category chosen in cases of doubt 2
  • Histologic Types: Include squamous cell carcinoma (various subtypes), salivary gland-type tumors, neuroendocrine carcinomas, and others 2

4. Salivary Gland Incidentalomas

  • TNM AJC/UICC Classification: Most practical for treatment decision-making 2
  • Histological Grading: Differentiating between low-grade vs high-grade tumors 2

5. Neuroblastic Incidentalomas

  • International Neuroblastoma Pathology Classification (INPC): Categorizes into favorable or unfavorable histology groups 2
  • Four main categories based on Schwannian stroma development:
    • Neuroblastoma (Schwannian stroma-poor)
    • Ganglioneuroblastoma, intermixed (Schwannian stroma-rich)
    • Ganglioneuroma (Schwannian stroma-dominant)
    • Ganglioneuroblastoma, nodular (composite)

6. Cutaneous Incidentalomas

  • Keratoacanthoma (KA): Classified on the border between benignity and malignancy 3, 4
    • Features rapid growth followed by spontaneous regression
    • Histologically similar to well-differentiated squamous cell carcinoma

7. Odontogenic Incidentalomas

  • Odontogenic Cysts: Include odontogenic keratocyst, calcifying odontogenic cyst, and glandular odontogenic cyst 5
  • Odontogenic Tumors: Include cystic ameloblastoma, calcifying epithelial odontogenic tumor, and others 5

Management Principles

Diagnostic Workup

  1. Tissue Sampling:

    • Adequate tissue sampling is essential for accurate classification
    • For neuroblastoma: Surgical resection, incisional biopsy (>1 cm³), or multiple tissue cores (10+ cores, 20-30 mm length) 2
    • For breast lesions: Image-guided or excisional biopsy to confirm diagnosis 1
  2. Imaging:

    • Site-specific imaging protocols should be followed
    • For rectal tumors: Endorectal ultrasound (ERUS) and MRI for T staging, MRI for N staging 2
    • For salivary gland tumors: CT scan or high-resolution ultrasound 2
  3. Histopathological Examination:

    • Complete specimen examination with appropriate margins
    • For lymph nodes: At least one section through the center of each node 2
    • For DCIS: Report nuclear grade, presence/absence of necrosis, and architectural patterns 2

Treatment Approaches

  1. Surgical Management:

    • Complete surgical excision is the standard treatment for most solid incidentalomas 2
    • Margins depend on the specific diagnosis and risk stratification
    • For DCIS: Margins based on nuclear grade and presence of necrosis 2
  2. Adjuvant Therapy:

    • For salivary gland tumors: Postoperative radiotherapy for high-grade tumors and incomplete resections 2
    • For ependymal tumors: Conformal radiotherapy based on WHO grade and extent of resection 2
  3. Observation:

    • For confirmed benign incidentalomas or those with low malignant potential
    • For fat necrosis: Regular clinical observation with most cases resolving spontaneously 1
    • For keratoacanthoma: Possible observation given tendency for spontaneous regression, though surgical excision often performed due to difficulty distinguishing from SCC 4

Risk Stratification Factors

  • Histological grade: Higher grade indicates greater risk
  • Size: Larger lesions generally carry higher risk
  • Location: Anatomical site affects prognosis and management
  • Patient factors: Age, comorbidities, and performance status

Follow-up Recommendations

  • Regular clinical examinations based on risk stratification
  • Site-specific imaging protocols
  • Long-term follow-up for lesions with risk of late recurrence

Common Pitfalls to Avoid

  1. Inadequate sampling: May lead to misclassification and inappropriate management
  2. Overdiagnosis: Particularly in fibroosseous lesions of the jaws 5
  3. Underdiagnosis: Especially for cystic ameloblastoma, which may lead to recurrence 5
  4. Failure to correlate clinically: Histopathological findings must be interpreted in clinical context

By following a systematic approach to classification and management of incidentalomas based on anatomical location and histopathological features, clinicians can ensure appropriate treatment while minimizing unnecessary interventions.

References

Guideline

Management of Fat Necrosis in Breast Cancer Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Keratoacanthoma (KA): An update and review.

Journal of the American Academy of Dermatology, 2016

Research

A clinical and biological review of keratoacanthoma.

The British journal of dermatology, 2021

Research

Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.